SLC30A1 and prostate carcinoma: SLC30A1 expression was increased and SLC39A8 decreased in MAC-MT cells in cancer compared to non-tumor samples (Figure 6B), the overall effect of which may be to increase zinc efflux, potentially counteracting the known decreased zinc concentration associated with prostate cancer.